Timing and Incidence of Postoperative Infections Associated with Blood Transfusion: Analysis of 1,489 Orthopedic and Cardiac Surgery Patients

Abstract

Patients should be followed for as long as four weeks after discharge to determine the true incidence and risk of ABT-associated PI.

Factors associated with blood transfusion in the postoperative period of cardiac surgery

“…In regards to clinical condition, a prevalence of patients with severe systemic disease (American Society of Anesthesiologists classification P3) was evident, which was similar to another study (SHANDER et al, 2009). Among the comorbidities, SAH was common, which was also observed in another study involving patients who received blood transfusions during cardiac surgery (BANBURY et al, 2006;KOCH et al, 2006;MOITINHO, 2008;;WERLANG et al, 2008;MOHNLE et al, 2010;DORNELES et al, 2011;WILLIAMS et al, 2011).…”

“…A study by Shander et al (2009) evaluated the need for blood transfusion in different types of surgeries, and observed that in orthopedic surgeries blood transfusion was necessary for only 15.7% of patients, while in cardiac surgeries the percentage rose to 55.6%.…”

Clinical and economic burden of postoperative pulmonary complications: Patient safety summit on definition, risk-reducing interventions, and preventive strategies*

“…The presence of PP is consistently associated with increased ICU and hospital LOS and a higher mortality rate (46,48,54,55). The independent risk factors that have been identified for PP include age Ͼ65 yrs, chronic obstructive pulmonary disease, trauma including burns, emergency surgery, prolonged duration of surgery, intraoperative transfusion, and postoperative tracheal reintubation (46,48,56).…”

Perioperative Red Blood Cell Transfusion: Harmful or Beneficial to the Patient?

“…Furthermore, these transfusion-associated infections do not necessarily occur within a short time period after transfusion. The limited data suggests that the incidence of postoperative infections is increased with a lag of as much as 4 weeks after application of the last erythrocyte concentrate [39], and therefore in daily clinical practice the onset of infection is rarely traced back to an erythrocyte concentrate administered weeks ago. Besides these risks, Castillo et al [40] discussed a hypothesis that there might be an association between blood transfusions and consecutive non-Hodgkin's lymphoma (NHL).…”